Literature DB >> 24909118

Emodin inhibits tonic tension through suppressing PKCδ-mediated inhibition of myosin phosphatase in rat isolated thoracic aorta.

Kyung-Min Lim1, Jae-Hyuk Kwon, Keunyoung Kim, Ji-Yoon Noh, Seojin Kang, Jung-Min Park, Moo-Yeol Lee, Ok-Nam Bae, Jin-Ho Chung.   

Abstract

BACKGROUND AND
PURPOSE: Dysregulated tonic tension and calcium sensitization in blood vessels has frequently been observed in many cardiovascular diseases. Despite a huge therapeutic potential, little is known about natural products targeting tonic tension and calcium sensitization. EXPERIMENTAL APPROACH: We screened natural products for inhibitory effects on vasoconstriction using the rat isolated thoracic aorta and found that an anthraquinone derivative, emodin, attenuated tonic tension. Organ bath system, primary vascular smooth muscle cells, confocal microscopy and Western blot analysis were employed to demonstrate the suppressive effects of emodin on PKCδ-mediated myosin phosphatase inhibition. KEY
RESULTS: Emodin, an active ingredient of Polygonum multiflorum extract, inhibited phenylephrine-induced vasoconstriction in rat isolated thoracic aorta, and inhibited vasoconstriction induced by 5-HT and endothelin-1. It also generally suppressed vasoconstrictions mediated by voltage-operated, store-operated calcium channels and intracellular calcium store. However, emodin did not affect agonist-induced calcium increases in primary smooth muscle cells. In contrast, post-treatment with emodin following phenylephrine stimulation potently suppressed tonic tension in rat aortic rings. Western blot analysis revealed that emodin inhibited phenylephrine-induced phospho-myosin light chain (pMLC) and the phosphorylation of myosin-targeting subunit and C-kinase-activated protein phosphatase-1 inhibitor (CPI-17). This was mediated by selective inhibition of PKCδ, whereas PKCα was not involved. CONCLUSION AND IMPLICATIONS: Emodin attenuates tonic tension through the blockade of PKCδ and CPI-17-mediated MLC-phosphatase inhibition. This new mode of action for the suppression of tonic tension and structural insights into PKCδ inhibition revealed by emodin may provide new information for the development of modulators of tonic tension and for the treatment of hypertension.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24909118      PMCID: PMC4241095          DOI: 10.1111/bph.12804

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension.

Authors:  Y Fukumoto; T Matoba; A Ito; H Tanaka; T Kishi; S Hayashidani; K Abe; A Takeshita; H Shimokawa
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 2.  Calcium sensitization as a pharmacological target in vascular smooth-muscle regulation.

Authors:  George Christ; Christopher Wingard
Journal:  Curr Opin Investig Drugs       Date:  2005-09

Review 3.  Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension.

Authors:  Daisy A Salamanca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2005-09-01       Impact factor: 5.858

4.  Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity.

Authors:  K Ichikawa; M Ito; D J Hartshorne
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

5.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.

Authors:  M Uehata; T Ishizaki; H Satoh; T Ono; T Kawahara; T Morishita; H Tamakawa; K Yamagami; J Inui; M Maekawa; S Narumiya
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

Review 6.  Distinctive activation mechanisms and functions for protein kinase Cdelta.

Authors:  Susan F Steinberg
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

7.  G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle.

Authors:  T Kitazawa; M Masuo; A P Somlyo
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

8.  Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells.

Authors:  S Satoh; R Kreutz; C Wilm; D Ganten; G Pfitzer
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice.

Authors:  Yoshihiko Chiba; Ayako Ueno; Koji Shinozaki; Hisao Takeyama; Shuji Nakazawa; Hiroyasu Sakai; Miwa Misawa
Journal:  Respir Res       Date:  2005-01-08

10.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more
  7 in total

1.  Propofol induces excessive vasodilation of aortic rings by inhibiting protein kinase Cβ2 and θ in spontaneously hypertensive rats.

Authors:  Yan Wang; Quanhong Zhou; Bin Wu; Huixuan Zhou; Xiaoli Zhang; Wei Jiang; Li Wang; Aizhong Wang
Journal:  Br J Pharmacol       Date:  2017-05-10       Impact factor: 8.739

Review 2.  Anthraquinones and Derivatives from Marine-Derived Fungi: Structural Diversity and Selected Biological Activities.

Authors:  Mireille Fouillaud; Mekala Venkatachalam; Emmanuelle Girard-Valenciennes; Yanis Caro; Laurent Dufossé
Journal:  Mar Drugs       Date:  2016-03-25       Impact factor: 5.118

3.  Endothelium-Independent Effect of Fisetin on the Agonist-Induced Regulation of Vascular Contractility.

Authors:  Hyun Dong Je; Uy Dong Sohn; Hyen-Oh La
Journal:  Biomol Ther (Seoul)       Date:  2016-01-01       Impact factor: 4.634

4.  INHIBITORY EFFECT OF EMODIN ON RAW 264.7 ACTIVATED WITH DOUBLE STRANDED RNA ANALOGUE POLY I:C.

Authors:  Young-Jin Kim; Ji Young Lee; Hyun-Ju Kim; Do-Hoon Kim; Tae Hee Lee; Mi Suk Kang; You-Kyung Choi; Hye Lim Lee; Jaieun Kim; Hyo-Jin An; Wansu Park
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-03-01

Review 5.  Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review.

Authors:  Longfei Lin; Boran Ni; Hongmei Lin; Miao Zhang; Xuechun Li; Xingbin Yin; Changhai Qu; Jian Ni
Journal:  J Ethnopharmacol       Date:  2014-11-18       Impact factor: 4.360

6.  Kang Le Xin Reduces Blood Pressure Through Inducing Endothelial-Dependent Vasodilation by Activating the AMPK-eNOS Pathway.

Authors:  Yixiu Zhao; Jiuxin Zhu; Hangfei Liang; Shuang Yang; Yannan Zhang; Weina Han; Chao Chen; Na Cao; Peiqiang Liang; Xing Du; Jian Huang; Jinhui Wang; Yan Zhang; Baofeng Yang
Journal:  Front Pharmacol       Date:  2020-01-22       Impact factor: 5.810

7.  Inhibitory mechanism of ginsenoside Rh3 on granulocyte-macrophage colony-stimulating factor expression in UV-B-irradiated murine SP-1 keratinocytes.

Authors:  Young Sun Park; Ji Eun Lee; Jong Il Park; Cheol Hwan Myung; Young-Ho Lim; Chae Kyu Park; Jae Sung Hwang
Journal:  J Ginseng Res       Date:  2018-12-24       Impact factor: 6.060

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.